Alibaba Health Information Technology Limited

SEHK:241 Stock Report

Market Cap: HK$51.0b

Alibaba Health Information Technology Management

Management criteria checks 2/4

Alibaba Health Information Technology's CEO is Difan Shen, appointed in Nov 2023, has a tenure of less than a year. total yearly compensation is CN¥6.41M, comprised of 23% salary and 77% bonuses, including company stock and options. directly owns 0.007% of the company’s shares, worth HK$3.70M. The average tenure of the management team and the board of directors is 0.9 years and 1.6 years respectively.

Key information

Difan Shen

Chief executive officer

CN¥6.4m

Total compensation

CEO salary percentage23.0%
CEO tenureless than a year
CEO ownership0.007%
Management average tenureless than a year
Board average tenure1.6yrs

Recent management updates

Recent updates

Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?

Mar 12
Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?

With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For

Jan 17
With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For

Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?

Jan 07
Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?

Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)

Dec 15
Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)

Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price

Sep 28
Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price

Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price

Jul 02
Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price

Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?

Jun 11
Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?

Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Jun 22
Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?

Dec 01
Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?

Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital

Oct 15
Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital

Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Aug 12
Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price

Jun 25
Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price

These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts

May 30
These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts

Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%

May 27
Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%

The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising

Mar 23
The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising

Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?

Mar 05
Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?

How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?

Feb 15
How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?

Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 31
Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?

If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today

Dec 31
If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today

Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Dec 16
Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?

Dec 01
Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?

CEO Compensation Analysis

How has Difan Shen's remuneration changed compared to Alibaba Health Information Technology's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

CN¥817m

Jun 30 2023n/an/a

CN¥675m

Mar 31 2023CN¥6mCN¥1m

CN¥533m

Dec 31 2022n/an/a

CN¥332m

Sep 30 2022n/an/a

CN¥128m

Jun 30 2022n/an/a

-CN¥69m

Mar 31 2022CN¥6mCN¥1m

-CN¥266m

Dec 31 2021n/an/a

-CN¥216m

Sep 30 2021n/an/a

-CN¥167m

Jun 30 2021n/an/a

CN¥91m

Mar 31 2021n/an/a

CN¥349m

Dec 31 2020n/an/a

CN¥313m

Sep 30 2020n/an/a

CN¥278m

Jun 30 2020n/an/a

CN¥136m

Mar 31 2020CN¥12mCN¥2m

-CN¥7m

Dec 31 2019n/an/a

-CN¥3m

Sep 30 2019n/an/a

CN¥1m

Jun 30 2019n/an/a

-CN¥40m

Mar 31 2019CN¥7mCN¥33k

-CN¥82m

Compensation vs Market: Difan's total compensation ($USD886.47K) is about average for companies of similar size in the Hong Kong market ($USD927.61K).

Compensation vs Earnings: Difan's compensation has been consistent with company performance over the past year.


CEO

Difan Shen (45 yo)

less than a year

Tenure

CN¥6,406,000

Compensation

Mr. Difan Shen serves as Chief Executive Officer of Alibaba Health Information Technology Limited from November 28, 2023 and serves as Executive Director since October 13, 2021. He was Chief Operating Offi...


Leadership Team

NamePositionTenureCompensationOwnership
Shunyan Zhu
Chairman of the Board4yrsCN¥11.33m0.0081%
CN¥ 4.1m
Difan Shen
CEO & Executive Directorless than a yearCN¥6.41m0.0073%
CN¥ 3.7m
Yanwu Tu
CFO & Executive Director3.9yrsCN¥3.24m0.0046%
CN¥ 2.3m
Hiu Leong Tsui
Legal Counsel & Joint Company Secretary1.2yrsno datano data
Chun Kwong
Financial Controllerno datano datano data
Deng Yan
Joint Company Secretaryless than a yearno datano data

0.9yrs

Average Tenure

45yo

Average Age

Experienced Management: 241's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Shunyan Zhu
Chairman of the Board4yrsCN¥11.33m0.0081%
CN¥ 4.1m
Difan Shen
CEO & Executive Director2.4yrsCN¥6.41m0.0073%
CN¥ 3.7m
Yanwu Tu
CFO & Executive Director3.4yrsCN¥3.24m0.0046%
CN¥ 2.3m
May Yihong Wu
Independent Non-Executive Directorless than a yearno datano data
Yi Fei Huang
Independent Non-Executive Director4.8yrsCN¥330.00kno data
Rong Shao
Independent Non-Executive Directorless than a yearno datano data
Jiaojiao Huang
Non-Executive Directorless than a yearno datano data
Haipeng Xu
Non-Executive Directorless than a yearno datano data

1.6yrs

Average Tenure

47yo

Average Age

Experienced Board: 241's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.